Cellular senescence in vivo: From cells to tissues to pathologies

Mech Ageing Dev. 2020 Sep:190:111308. doi: 10.1016/j.mad.2020.111308. Epub 2020 Jul 2.

Abstract

Senescent cells accumulate during aging in a variety of tissues. Although scarce, they could influence tissue function non-cell-autonomously via secretion of a range of factors in their neighborhood. Recent studies support a role of senescent cells in age-related morbidity, including neurodegenerative diseases, cardiovascular pathologies, cancers, aging-associated nephrological alterations, chronic pulmonary disease and osteoarthritis, indicating that senescent cells could represent an interesting target for therapeutic exploitation across a range of pathophysiological contexts. In this article, we review data available to indicate which cell types can undergo senescence within various mammalian tissue environments and how these processes may contribute to tissue-specific pathologies associated with old age. We also consider markers used to identify senescent cells in vitro and in vivo. The data discussed may serve as an important starting point for an extended definition of molecular and functional characteristics of senescent cells in different organs and may hence promote the development and refinement of targeting strategies aimed at removing senescent cells from aging tissues.

Keywords: Age-Related diseases; Aging; In vivo senescence; SASP; Senescent cell types.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging* / pathology
  • Aging* / physiology
  • Biomarkers / analysis
  • Cellular Senescence / physiology*
  • Chronic Disease*
  • Humans

Substances

  • Biomarkers